Connect your AI

Xenon Pharmaceuticals XENE Price / book

Price / book at other companies

Eli LillyLLY

26.3×-20.7×

Johnson & JohnsonJNJ

7.3×+2.1×

Jazz PharmaceuticalsJAZZ

2.6×+0.8×

Axsome TherapeuticsAXSM

158.4×+51.5×

Praxis Precision Medicines, Inc.PRAX

6.4×+4.6×

Neurocrine BiosciencesNBIX

3.9×-0.5×

Other financials

Income statement

Revenue--100%

Operating income-$112.3M-54.4%

Net income-$102.3M-57.3%

EPS (diluted)-$1.17-41.0%

Balance sheet

Cash & equivalents$545.9M+368%

Total debt$7.5M-13.6%

Total equity$1.3B+90.0%

Total assets$1.4B+86.6%

Cash flow

Operating cash flow-$88.9M-44.2%

CapEx$133.0K+209%

Free cash flow-$89.0M-44.3%

Valuation

Market cap$5.11B+116%

Enterprise value$4.58B+104%

Profitability

Operating margin-4,974.3%—

Net margin-4,612.1%—

FCF margin-3,732.2%—

Returns & leverage

Return on equity-37.5%+8.7pp

Debt / equity0×0.0×

Current ratio27.8×+10.1×

Where this comes from

Calculated from Xenon Pharmaceuticals’s reported figures.

market cap/total stockholders equity=4.1×

Based on the most recent quarter.

The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xenon Pharmaceuticals's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Xenon Pharmaceuticals's price / book?: Xenon Pharmaceuticals (XENE) reported price / book of 4.1× in Q1 2026.
How has Xenon Pharmaceuticals's price / book changed year-over-year?: Xenon Pharmaceuticals's price / book increased by 13.7% year-over-year, from 3.6× to 4.1×.
What is the long-term trend for Xenon Pharmaceuticals's price / book?: Over 5 years (2020 to 2025), Xenon Pharmaceuticals's price / book has grown at a 5.2% compound annual growth rate (CAGR), from 4.6× to 6×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.